PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-alpha1.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26540149 ↗2016Reported benefit

Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-alpha1.

RatChemical/toxinSprague-Dawleymalen = 10 rats per group across 4 groupsgiven during the 3 h of mechanical ventilation after acid instillation

Model: Acute lung injury by intratracheal instillation of hydrogen chloride followed by mechanical ventilation at tidal volume 6 mL/kg and PEEP 8 cm H2O for 3 h

Cisatracurium and pancuronium improved respiratory compliance and oxygenation and lowered plasma tumour necrosis factor alpha and interleukin 6 after acid-induced lung injury, with the anti-inflammatory effect reproduced by silencing nicotinic acetylcholine receptor alpha1 in human cells.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.